Advertisement
Screener

CLARITEV CORPORATION (CTEV) Overview

CLARITEV CORPORATION (CTEV) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual -3.49; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual -4.41; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -4.23; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -3.81; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$12.80$18.11$25.64$36.29$51.37$72.712025-11-062026-11-06$4.95$10.91$24.04$53.00$116.81$257.462021-11-082026-11-06$4.95$12.47$31.42$79.18$199.52$502.742020-04-032026-11-06$4.95$12.47$31.42$79.18$199.52$502.742020-04-032026-11-06$4.95$12.47$31.42$79.18$199.52$502.742020-04-032026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$22.75
Previous close
$21.64
Change
$1.11
Change (%)
5.11%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

CTEV
-49.38%
S&P 500
(m)

1 year

CTEV
-58.87%
S&P 500
(m)

3 years

CTEV
-67.80%
S&P 500
(m)

5 years

CTEV
-90.23%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual -3.49

-4.49-4.20-3.90-3.60-3.3131 Mar 2025: estimate (m); actual -4.3831 Mar 2025(m)30 Jun 2025: estimate (m); actual -3.8130 Jun 2025(m)30 Sept 2025: estimate (m); actual -4.2330 Sept 2025(m)31 Mar 2026: estimate (m); actual -4.4131 Mar 2026(m)30 Jun 2026: estimate (m); actual -3.4930 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)-3.49(m)(m)
1 Jan 202631 Mar 2026(m)-4.41(m)(m)
1 Jul 202530 Sept 2025(m)-4.23(m)(m)
1 Apr 202530 Jun 2025(m)-3.81(m)(m)
1 Jan 202531 Mar 2025(m)-4.38(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -17.30

-102.00-76.41-50.83-25.250.3431 Dec 2021: estimate (m); actual 0.1631 Dec 2021(m)31 Dec 2022: estimate (m); actual -0.9031 Dec 2022(m)31 Dec 2023: estimate (m); actual -5.6931 Dec 2023(m)31 Dec 2024: estimate (m); actual -101.9231 Dec 2024(m)31 Dec 2025: estimate (m); actual -17.3031 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-17.30(m)(m)
1 Jan 202431 Dec 2024(m)-101.92(m)(m)
1 Jan 202331 Dec 2023(m)-5.69(m)(m)
1 Jan 202231 Dec 2022(m)-0.90(m)(m)
1 Jan 202131 Dec 2021(m)0.16(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 257.48M ■ Earnings -59.23M — Profit margin -23.00%

-121.14M-33.7%18.59M-29.8%158.32M-25.9%298.04M-22.0%30 Sept 2025: revenue 245.96M; earnings -69.75M; profit margin -28.36%30 Sept 202531 Dec 2025: revenue 246.55M*; earnings -80.57M*; profit margin -32.68%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 244.68M; earnings -73.56M; profit margin -30.06%31 Mar 202630 Jun 2026: revenue 257.48M; earnings -59.23M; profit margin -23.00%30 Jun 2026

31 Dec 2025 ■ Revenue 0.97B ■ Earnings -0.28B — Profit margin -29.45%

-1.97B-177.9%-0.85B-121.4%0.28B-65.0%1.41B-8.5%31 Dec 2022: revenue 1.08B; earnings -0.57B; profit margin -53.06%31 Dec 202231 Dec 2023: revenue 0.96B; earnings -0.09B; profit margin -9.54%31 Dec 202331 Dec 2024: revenue 0.93B; earnings -1.65B; profit margin -176.85%31 Dec 202431 Dec 2025: revenue 0.97B; earnings -0.28B; profit margin -29.45%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$22.75(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$22.75High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning CTEV

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$-283.11M
Profit margin
-28.46%
Return on assets · 12 month
-5.76%
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
145.48K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-26.52%*
Total return · month
-45.06%*
Total return · quarter
-36.01%*
Total return · half year
39.25%*
Total return · year to date
-49.38%*
Total return · 1 year
-58.87%*
Total return · 3 years
-67.80%*
Total return · 5 years
-90.23%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$994.67M
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

CLARITEV CORPORATION Overview

View more →

(m)

(m)

SEC CIK
1793229
Industry (SIC)
7389 Services-Business Services, NEC
Country of operation
United States
Business address
7900 TYSONS ONE PLACE, SUITE 400, MCLEAN, Virginia, 22102, United States
Fiscal year end
1231
Phone
866-909-7427

Similar stocks

Stock NameCountryMarket CapPE Ratio
Rimini Street, Inc. (RMNI)United States$0.401B54.39
Advantage Solutions Inc. (ADV)United States$0.435B-2.00
International Money Express, Inc. (IMXI)United States$0.320B23.44
Outdoor Holding Co (POWW)United States$0.270B40.73
CONDUENT Inc (CNDT)United States$0.253B-1.00
DHI GROUP, INC. (DHX)United States$0.205B132.15
Phreesia, Inc. (PHR)United States$0.621B63.46
TEN Holdings, Inc. (XHLD)United States$0.152B
Priority Technology Holdings, Inc. (PRTH)United States$0.643B9.77
OptimizeRx Corp (OPRX)United States$0.149B23.33